These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 15557707)

  • 1. Cholesterol-independent effects of statins and new therapeutic targets: ischemic stroke and dementia.
    Miida T; Hirayama S; Nakamura Y
    J Atheroscler Thromb; 2004; 11(5):253-64. PubMed ID: 15557707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of stroke and dementia by statin therapy: experimental and clinical evidence of their pleiotropic effects.
    Miida T; Takahashi A; Ikeuchi T
    Pharmacol Ther; 2007 Feb; 113(2):378-93. PubMed ID: 17113151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of stroke and dementia with statins: Effects beyond lipid lowering.
    Vaughan CJ
    Am J Cardiol; 2003 Feb; 91(4A):23B-29B. PubMed ID: 12615295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do statins afford neuroprotection in patients with cerebral ischaemia and stroke?
    Vaughan CJ; Delanty N; Basson CT
    CNS Drugs; 2001; 15(8):589-96. PubMed ID: 11524031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The evolving role of statins in the management of atherosclerosis.
    Vaughan CJ; Gotto AM; Basson CT
    J Am Coll Cardiol; 2000 Jan; 35(1):1-10. PubMed ID: 10636252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of pleiotropic effects of statins in dementia.
    Crisby M
    Acta Neurol Scand Suppl; 2006; 185():115-8. PubMed ID: 16866920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins excert neuroprotection on cerebral ischemia independent of their lipid-lowering action: the potential molecular mechanisms.
    Li Q; Zhuang QK; Yang JN; Zhang YY
    Eur Rev Med Pharmacol Sci; 2014; 18(8):1113-26. PubMed ID: 24817284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins in the treatment of acute ischemic stroke.
    Montecucco F; Quercioli A; Mirabelli-Badenier M; Viviani GL; Mach F
    Curr Pharm Biotechnol; 2012 Jan; 13(1):68-76. PubMed ID: 21470160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advantages of lipid-lowering therapy in cerebral ischemia: role of HMG-CoA reductase inhibitors.
    Gil-Núñez AC; Villanueva JA
    Cerebrovasc Dis; 2001; 11 Suppl 1():85-95. PubMed ID: 11244205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins in ischemic stroke: just low-density lipoprotein lowering or more?
    Stead LG; Vaidyanathan L; Kumar G; Bellolio MF; Brown RD; Suravaram S; Enduri S; Gilmore RM; Decker WW
    J Stroke Cerebrovasc Dis; 2009; 18(2):124-7. PubMed ID: 19251188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct vascular effects of HMG-CoA reductase inhibitors.
    Laufs U; Liao JK
    Trends Cardiovasc Med; 2000 May; 10(4):143-8. PubMed ID: 11239793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of the inflammatory process by statins.
    Crisby M
    Drugs Today (Barc); 2003 Feb; 39(2):137-43. PubMed ID: 12698208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of statins on prevention of stroke and dementia: a review.
    Menezes AR; Lavie CJ; Milani RV; OʼKeefe J
    J Cardiopulm Rehabil Prev; 2012; 32(5):240-9. PubMed ID: 22785147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and ischemic stroke.
    Liao JK
    Atheroscler Suppl; 2002 May; 3(1):21-5. PubMed ID: 12044582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Werner N; Nickenig G; Laufs U
    Basic Res Cardiol; 2002 Mar; 97(2):105-16. PubMed ID: 12002257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
    Robinson JG
    Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of the inflammatory process by statins.
    Crisby M
    Timely Top Med Cardiovasc Dis; 2005 Mar; 9():E3. PubMed ID: 15824762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin therapy-evidence beyond lipid lowering contributing to plaque stability.
    de Lorenzo F; Feher M; Martin J; Collot-Teixeira S; Dotsenko O; McGregor JL
    Curr Med Chem; 2006; 13(28):3385-93. PubMed ID: 17168712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Bocan TM
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.